Makes adjustable lenses for cataract surgery patients.
Jun 2026Revenue $121M/yrExpenses $176M/yr
No trendCash runway ≈ 7.7 years from Jun 2026
Figures by year
When will RxSight be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $121M and expenses $176M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $134M | $183M | −$48.2M |
| Dec 2024 | $140M | $177M | −$36.9M |
| Dec 2023 | $89.1M | $139M | −$50.1M |
| Dec 2022 | $49.0M | $112M | −$63.3M |
| Dec 2021 | $22.6M | $75.4M | −$52.8M |
| Dec 2020 | $14.7M | $50.1M | −$35.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.